Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Vivanza Biosciences Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.0010.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax-0.670.700.720.000.12
      
Net CashFlow From Operating Activities-2.502.04-0.950.00-2.76
Net Cash Used In Investing Activities-0.01-0.040.000.00-0.02
Net Cash Used From Financing Activities2.46-1.981.030.002.47
      
Net Inc/Dec In Cash And Cash Equivalents-0.050.030.090.00-0.32
Cash And Cash Equivalents Begin of Year0.170.140.060.00-2.78
Cash And Cash Equivalents End Of Year0.120.170.140.00-3.09
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax-0.67
Net CashFlow From Operating Activities-2.50
Net Cash Used In Investing Activities-0.01
Net Cash Used From Financing Activities2.46
Net Inc/Dec In Cash And Cash Equivalents-0.05
Cash And Cash Equivalents Begin of Year0.17
Cash And Cash Equivalents End Of Year0.12